share_log

Organogenesis Announces Plans To Expand Manufacturing Capacity With A Long-Term Lease A Biomanufacturing Facility Located At 100 Technology Way In Smithfield, Rhode Island

Organogenesis Announces Plans To Expand Manufacturing Capacity With A Long-Term Lease A Biomanufacturing Facility Located At 100 Technology Way In Smithfield, Rhode Island

Organogenesis宣佈計劃通過與位於羅德島史密斯菲爾德的100科技大道的生物製造設施簽訂長期租約來擴展製造業-半導體的產能。
Benzinga ·  2024/11/22 21:09

Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, announced plans to expand manufacturing capacity with a long-term lease for a 122,000-square foot state-of-the-art biomanufacturing facility located at 100 Technology Way in Smithfield, Rhode Island.

Organogenesis控股公司(納斯達克:ORGO),一家領先的再生醫學公司,專注於開發、製造和商業化在Advanced Wound Care和手術及體育醫學市場產品解決方案,宣佈計劃通過租賃長期租約,擴大在羅德島史密斯菲爾德市100 Technology Way的122,000平方英尺最先進的生物製造設施的製造能力。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論